LEADER 07401nam 2200601 a 450 001 9910827562503321 005 20240416233514.0 010 $a1-280-19633-5 010 $a9786610196333 010 $a0-309-58463-9 010 $a0-585-02015-9 035 $a(CKB)110986584751198 035 $a(OCoLC)42328757 035 $a(CaPaEBR)ebrary10055262 035 $a(SSID)ssj0000145894 035 $a(PQKBManifestationID)11158198 035 $a(PQKBTitleCode)TC0000145894 035 $a(PQKBWorkID)10182167 035 $a(PQKB)11595024 035 $a(Au-PeEL)EBL3376238 035 $a(CaPaEBR)ebr10055262 035 $a(OCoLC)923262253 035 $a(MiAaPQ)EBC3376238 035 $a(EXLCZ)99110986584751198 100 $a19920715d1992 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEmerging infections $emicrobial threats to health in the United States /$fJoshua Lederberg, Robert E. Shope, and Stanley C. Oaks, Jr., editors 205 $a1st ed. 210 $aWashington, D.C. $cNational Academy Press$d1992 215 $a1 online resource (308 p.) 300 $a"Committee on Emerging Microbial Threats to Health, Division of Health Sciences Policy, Division of International Health, Institute of Medicine." 311 $a0-309-04741-2 320 $aIncludes bibliographical references (p. 170-191) and index. 327 $aEMERGING INFECTIONS -- Copyright -- Preface -- Acknowledgments -- Contents -- Executive Summary -- RECOGNITION -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- Public Education and Behavioral Change -- 1 Background -- PLAGUE -- INFLUENZA -- OPTIMISM AND INDIFFERENCE -- Sanitation and Hygiene -- Quarantine -- Smallpox -- Poliomyelitis -- TROUBLE AHEAD -- Lyme Disease -- Peptic Ulcer -- Malaria -- Dengue -- Tuberculosis -- NEXT STEPS -- 2 Factors in Emergence -- THE CONCEPT OF EMERGENCE -- HUMAN DEMOGRAPHICS AND BEHAVIOR -- Population Growth, Density, and Distribution -- DENGUE -- Immunosuppression -- Sexual Activity and Substance Abuse -- TECHNOLOGY AND INDUSTRY -- Modern Medicine -- HEALTH CARE DELIVERY -- PREVENTION OF NOSOCOMIAL INFECTIONS -- Food Processing and Handling -- AGRICULTURAL CONDITIONS AND PRACTICES -- FOOD PROCESSING AND PRESERVATION TECHNOLOGIES -- DEMOGRAPHICS -- CONSUMER ATTITUDES AND BEHAVIOR -- COMMERCE -- DIET AND FOOD PREPARATION -- Trichinosis -- Anisakiasis -- Water Treatment -- ECONOMIC DEVELOPMENT AND LAND USE -- Dam Building and Rift Valley Fever -- Reforestation and Lyme Disease -- Global Warming -- INTERNATIONAL TRAVEL AND COMMERCE -- Travel -- MALARIA -- Commerce -- HANTAAN AND RELATED HANTAVIRUSES -- THE FILOVIRUSES -- MICROBIAL ADAPTATION AND CHANGE -- Natural Variation/Mutation -- RNA VIRUSES -- Influenza A Virus -- Human Immunodeficiency Virus -- DNA VIRUSES -- Hepatitis B Virus -- BACTERIA -- Brazilian Purpuric Fever -- Selective Pressure and the Development of Resistance -- RESISTANCE TO ANTIBIOTICS -- Pneumococci -- Staphylococci and Enterococci -- Pseudomonas aeruginosa -- Mycobacterium tuberculosis -- RESISTANCE TO ANTIVIRALS -- Acyclovir and Herpes Simplex Virus. 327 $aZidovudine and Human Immunodeficiency Virus-1 -- RESISTANCE TO ANTIMALARIALS -- VECTOR RESISTANCE TO PESTICIDES -- New Understandings: Microbes as Cofactors in Chronic Disease -- HUMAN T-CELL LEUKEMIA VIRUS TYPES I AND II -- ATHEROSCLEROSIS -- HUMAN PAPILLOMAVIRUS -- BREAKDOWN OF PUBLIC HEALTH MEASURES -- Inadequate Sanitation: Cholera -- Complacency -- INADEQUATE LEVELS OF IMMUNIZATION: MEASLES -- War -- 3 Addressing the Threats -- RECOGNITION -- Surveillance in Action: The World Health Organization's Smallpox Eradication Program -- LESSONS FROM THE SMALLPOX EXPERIENCE -- Current U.S.-Supported Surveillance Efforts -- DOMESTIC EFFORTS -- Notifiable Diseases Surveillance -- Nosocomial Infections Surveillance -- Outbreak Surveillance -- Influenza Surveillance -- Access to Surveillance Information -- INTERNATIONAL EFFORTS -- Past Successes -- Loss of Capacity -- Current Efforts -- Multilateral International Surveillance Efforts -- WORLD HEALTH ORGANIZATION -- PAN AMERICAN HEALTH ORGANIZATION -- The Concept of Global Surveillance -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- THE ROCKEFELLER FOUNDATION -- NATIONAL INSTITUTES OF HEALTH -- CENTERS FOR DISEASE CONTROL -- DEPARTMENT OF DEFENSE -- OTHER PROGRAMS -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- VECTOR-CONTROL RESOURCES -- PESTICIDES FOR VECTOR CONTROL -- Public Education and Behavioral Change -- References -- Appendixes -- A Task Forces -- TASK FORCE 1 -- Bacteria, Rickettsiae, and Chlamydiae -- TASK FORCE 2 -- Viruses -- TASK FORCE 3 -- Protozoans, Helminths, and Fungi -- TASK FORCE 4 -- Policy Options -- TASK FORCE 5 -- Recommendations -- B Catalog of Emerging Infectious Disease Agents -- EMERGENT BACTERIA, RICKETTSIAE, AND CHLAMYDIAE -- Aeromonas -- Borrelia burgdorferi -- Campylobacter jejuni. 327 $aChlamydia pneumoniae (TWAR Strain) -- Chlamydia trachomatis -- Clostridium difficile -- Ehrlichia chaffeensis -- Escherichia coli O157:H7 -- Haemophilus influenzae biogroup aegyptius -- Helicobacter pylori -- Legionella pneumophila -- Listeria monocytogenes -- Mycobacterium tuberculosis -- Staphylococcus aureus (and Toxic Shock Syndrome) -- Streptococcus pyogenes (Group A) -- Vibrio cholerae -- Vibrio vulnificus -- EMERGENT VIRUSES -- Bovine Spongiform Encephalopathy Agent -- California Serogroup Viruses (LaCrosse, Jamestown Canyon, California Encephalitis) -- Chikungunya Virus -- Crimean-Congo Hemorrhagic Fever Virus -- Dengue Virus -- Filoviruses (Marburg, Ebola) -- Hantaviruses (Hantaan, Puumala, and Seoul) -- Hepatitis B Virus -- Hepatitis C Virus -- Hepatitis E Agent -- Human Herpesvirus-6 -- Human Immunodeficiency Virus (HIV), Types 1 and 2 -- Human Papillomavirus (HPV) -- Human Parvovirus B19 -- Human T-Cell Leukemia Virus (HTLV), Types 1 and 2 -- Influenza A Virus -- Japanese Encephalitis Virus -- Lassa Virus -- Measles Virus -- Norwalk and Norwalk-like Agents -- Rabies Virus -- Rift Valley Fever Virus -- Ross River Virus -- Rotavirus -- Venezuelan Equine Encephalitis (VEE) Virus -- Yellow Fever Virus -- EMERGENT PROTOZOANS, HELMINTHS, AND FUNGI -- Anisakis -- Babesia -- Candida -- Crytococcus -- Cryptosporidium -- Giardia lamblia -- Microsporidia -- Plasmodium -- Pneumocystis carinii -- Strongyloides stercoralis -- Toxoplasma gondii -- C Global Resources for Infectious Disease Surveillance -- U.S. and U.S. Affiliated -- U.S. Department of Defense -- Public Health Service -- International -- World Health Organization, Geneva, Switzerland -- Pasteur Institutes -- D Committee and Staff Biographies -- COMMITTEE -- STAFF -- Glossary -- Acronyms and Abbreviations -- Index. 606 $aEmerging infectious diseases$zUnited States 615 0$aEmerging infectious diseases 676 $a614.4/273 701 $aLederberg$b Joshua$095738 701 $aShope$b Robert E$01703112 701 $aOaks$b S. C$01653257 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910827562503321 996 $aEmerging infections$94088082 997 $aUNINA